Therapeutic evaluation of cisplation plus interleukin-Ⅱin malignant hydrothorax and ascites
YUAN Yut-fang
CHANG Ai-qin
WANG Xiao-jin
Abstract：Objective: To boserve therapeutic effectiveness of cisplatin plus interleukin-l in malignant hydrothorax and as-cites. Methos: In experimental group, 45 cases were injected interleukin-Ⅱ and cisplation into thoracic cavity or abdominalcavity once a week, 3-6 weeks as one cylce. As a control group,40 cases were injected cisplation alone in the same way. Re-sults: The total effective rate in experimental group was 89% ,about 90% in hydrothorax,89% in ascites. The rates in controlgroup were 70%, 72.2 % and 68.2 %, respectively. Conclusion: Interleukin-Ⅱ and cisplatin were synergistic in treating ma-lignatn hydrothorax and ascites. Statistic management was significant(χ2=4.72, P＜0.05). It has practical value of extendingto clinical appliction.
Keywords：cisplatininterleukin-Ⅱmalignant hydrothorax and ascitesthoracic cavity and intraperitoneal injection
Publication Date：2000-01-01
Online Publishing Date：2026-09-12(First online date of this platform, not the publication date of the document)
Pages：2( 331-332 )